LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10442

Search options

  1. Book ; Online: Building Energy-Saving Technology

    Lin, Yaolin / Yang, Wei / Yang, Wei

    2023  

    Keywords Technology: general issues ; History of engineering & technology ; Environmental science, engineering & technology ; hotel energy conservation ; TPB ; personal norms ; past behaviour ; self-determination ; guest behaviour ; pro-environmental behaviour ; carbon peak ; carbon neutrality ; energy consumption ; vacuum refrigerator ; sealing door ; TRNSYS 16 ; MRT ; SET* ; surface temperature ; latitudes ; thermal environment ; urban building energy modelling ; physical-based bottom-up ; building energy use ; building types ; thermal bridges ; thermal transmittance ; thermal insulation ; passive energy buildings ; window ; building envelop ; solar-assisted heat pump (SAHP) ; energy efficiency ; research and development ; China ; nZEB buildings ; energy codes ; building energy models ; Código Técnico de la Edificación ; thermal waves ; comfort ; data-driven ; electricity consumption ; prediction model ; gas consumption ; building efficiency ; energy saving ; sustainable building ; thermal conductivity ; 3D printing ; 3D-printed concrete walls ; building energy efficiency ; passive house ; apartment ; ventilative cooling ; sunshade ; structural insulated panels (SIPs) ; thermal analyses ; multi-scale finite element modeling ; parametric analysis ; emergy ; production-living-ecology ; human settlement unit ; system dynamic ; emergy evaluation indices ; semitransparent PV ; colored PV ; BIPV ; net-zero energy building ; sustainable environment ; energy disaggregation ; non-intrusive load monitoring ; multi-target learning ; home energy monitoring ; n/a
    Language English
    Size 1 electronic resource (302 pages)
    Publisher MDPI - Multidisciplinary Digital Publishing Institute
    Publishing place Basel
    Document type Book ; Online
    Note English
    HBZ-ID HT030645347
    ISBN 9783036593036 ; 3036593039
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Article ; Online: The risk of all-cause death with dapagliflozin versus placebo: a systematic review and meta-analysis of phase III randomized controlled trials.

    Chen, Hai-Bin / Meng, Rong-Sen / Yang, Yao-Lin / Yu, Tian-Hao

    Expert opinion on drug safety

    2023  Volume 22, Issue 2, Page(s) 133–140

    Abstract: Background: Dapagliflozin has proven cardioprotective and nephroprotective effects. However, the risk of all-cause death with dapagliflozin remains unclear.: Research design and methods: We performed a meta-analysis of phase III randomized controlled ...

    Abstract Background: Dapagliflozin has proven cardioprotective and nephroprotective effects. However, the risk of all-cause death with dapagliflozin remains unclear.
    Research design and methods: We performed a meta-analysis of phase III randomized controlled trials (RCTs) for the risk of all-cause death and safety events with dapagliflozin compared to placebo. PubMed and EMBASE were searched from inception to 20 September 2022.
    Results: Five trials were included in the final analysis. Compared with the placebo, dapagliflozin demonstrated an 11.2% reduction in the risk of all-cause death (OR 0.88, 95% CI 0.81-0.94). No statistically significant difference in urinary tract infection (OR: 0.95, 95% CI: 0.78 to 1.17), bone fracture (OR: 1.06, 95% CI: 0.94 to 1.20), and amputation (OR: 1.01, 95% CI: 0.82 to 1.23) was observed between patients treated with dapagliflozin and placebo. Compared with placebo, dapagliflozin was associated with a significant reduction in acute kidney injury (OR: 0.71, 95% CI: 0.60 to 0.83), and increased the risk of genital infection (OR: 8.21, 95% CI: 4.19 to 16.12).
    Conclusions: Dapagliflozin was associated with significantly reduced all-cause death and increased genital infection. Dapagliflozin was safe concerning urinary tract infection, bone fracture, amputation, and acute kidney injury, compared with the placebo.
    MeSH term(s) Humans ; Hypoglycemic Agents/adverse effects ; Diabetes Mellitus, Type 2/drug therapy ; Randomized Controlled Trials as Topic ; Benzhydryl Compounds/adverse effects ; Urinary Tract Infections/chemically induced ; Urinary Tract Infections/drug therapy ; Acute Kidney Injury/chemically induced ; Fractures, Bone/epidemiology ; Fractures, Bone/prevention & control ; Fractures, Bone/chemically induced
    Chemical Substances dapagliflozin (1ULL0QJ8UC) ; Hypoglycemic Agents ; Benzhydryl Compounds
    Language English
    Publishing date 2023-02-26
    Publishing country England
    Document type Meta-Analysis ; Systematic Review ; Journal Article
    ZDB-ID 2088728-0
    ISSN 1744-764X ; 1474-0338
    ISSN (online) 1744-764X
    ISSN 1474-0338
    DOI 10.1080/14740338.2023.2182290
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Indirect comparison of SGLT2 inhibitors in patients with established heart failure: evidence based on Bayesian methods.

    Chen, Hai-Bin / Yang, Yao-Lin / Meng, Rong-Sen / Liu, Xue-Wei

    ESC heart failure

    2023  Volume 10, Issue 2, Page(s) 1231–1241

    Abstract: Aims: Head-to-head comparisons among SGLT2 inhibitors treatments in established heart failure remain absent. We conducted a systematic review of dedicated heart failure trials to assess indirectly the composite outcomes and individual clinical endpoints ...

    Abstract Aims: Head-to-head comparisons among SGLT2 inhibitors treatments in established heart failure remain absent. We conducted a systematic review of dedicated heart failure trials to assess indirectly the composite outcomes and individual clinical endpoints among SGLT2 inhibitor treatments.
    Methods and results: We systematically reviewed randomized controlled trials comparing SGLT2 inhibitors versus placebo in patients with established heart failure. A Bayesian approach to network meta-analysis was applied. Five trials including four treatment strategies were included in this study. The composite of cardiovascular death or hospitalization for heart failure showed no significant difference in the comparison between dapagliflozin and empagliflozin (OR 1.00, 95% CI 0.66-1.55), dapagliflozin and sotagliflozin (OR 1.54, 95% CI 0.91-2.65), and empagliflozin and sotagliflozin (OR 1.53, 95% CI 0.90-2.69). All-cause mortality showed no significant difference in the comparison between dapagliflozin and empagliflozin (OR 0.92, 95% CI 0.711-1.18), dapagliflozin and sotagliflozin (OR 1.05, 95% CI 0.68-1.59), and empagliflozin and sotagliflozin (OR 1.14, 95% CI 0.74-1.73). Cardiovascular death showed no significant difference in the comparison between dapagliflozin and empagliflozin (OR 0.94, 95% CI 0.71-1.23), dapagliflozin and sotagliflozin (OR 0.96, 95% CI 0.61-1.55), and empagliflozin and sotagliflozin (OR 1.03, 95% CI 0.64-1.66). Hospitalization for heart failure showed no significant difference in the comparison between dapagliflozin and empagliflozin (OR 1.13, 95% CI 0.64-1.97), dapagliflozin and sotagliflozin (OR 1.56, 95% CI 0.74-3.15), and empagliflozin and sotagliflozin (OR 1.39, 95% CI 0.68-2.78).
    Conclusions: In patients with established heart failure, there was no significant difference of the major efficacy outcomes among SGLT2 inhibitor treatments; however, sotagliflozin may be associated with the lowest risk of the composite of cardiovascular death or hospitalization for heart failure, and dapagliflozin may be associated with the lowest risk of all-cause and cardiovascular mortality.
    MeSH term(s) Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Bayes Theorem ; Diabetes Mellitus, Type 2/complications ; Heart Failure/drug therapy ; Heart Failure/complications
    Chemical Substances empagliflozin (HDC1R2M35U) ; Sodium-Glucose Transporter 2 Inhibitors ; dapagliflozin (1ULL0QJ8UC)
    Language English
    Publishing date 2023-01-26
    Publishing country England
    Document type Systematic Review ; Meta-Analysis ; Journal Article
    ZDB-ID 2814355-3
    ISSN 2055-5822 ; 2055-5822
    ISSN (online) 2055-5822
    ISSN 2055-5822
    DOI 10.1002/ehf2.14297
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Chi-lin sheng chung tung pu shih yung yao yung yu tu mo ku

    Yang, Ch'eng-lu / Chiang, Yu-Yü / Yang, Ching-lung

    1990  

    Title translation Edible, medicinal and poisonous mushrooms in the middle east part of Kirin Province.
    Author's details Yang Ch'eng-lu, Chiang Yu-yü, Yang Ching-lung pien chu
    Keywords Mushrooms/Identification. ; Edible mushrooms/Identification.
    Language Chinese
    Size 12, 328 p. :, ill. ;, 19 cm.
    Edition Ti 1 pan.
    Publisher Chi-lin jen min ch'u pan she
    Publishing place Ch'ang-ch'un shih
    Document type Book
    Note Includes indexes.
    ISBN 7206006876 ; 9787206006876
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: In Situ Probing the Structure Change and Interaction of Interfacial Water and Hydroxyl Intermediates on Ni(OH)

    Ze, Huajie / Yang, Zhi-Lan / Li, Mu-Lin / Zhang, Xia-Guang / A, Yao-Lin / Zheng, Qing-Na / Wang, Yao-Hui / Tian, Jing-Hua / Zhang, Yue-Jiao / Li, Jian-Feng

    Journal of the American Chemical Society

    2024  

    Abstract: There is growing acknowledgment that the properties of the electrochemical interfaces play an increasingly pivotal role in improving the performance of the hydrogen evolution reaction (HER). Here, we present, for the first time, direct dynamic spectral ... ...

    Abstract There is growing acknowledgment that the properties of the electrochemical interfaces play an increasingly pivotal role in improving the performance of the hydrogen evolution reaction (HER). Here, we present, for the first time, direct dynamic spectral evidence illustrating the impact of the interaction between interfacial water molecules and adsorbed hydroxyl species (OH
    Language English
    Publishing date 2024-04-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/jacs.4c00948
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: SGLT2 inhibitors for the composite of cardiorenal outcome in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.

    Chen, Hai-Bin / Yang, Yao-Lin / Yu, Tian-Hao / Li, Yu-Hui

    European journal of pharmacology

    2022  Volume 936, Page(s) 175354

    Abstract: To conduct a systematic review and meta-analysis of specific chronic kidney disease (CKD) trials focusing on the composite of cardiorenal outcome, and assess indirectly the clinical outcome of treatments with three inhibitors of sodium-glucose ... ...

    Abstract To conduct a systematic review and meta-analysis of specific chronic kidney disease (CKD) trials focusing on the composite of cardiorenal outcome, and assess indirectly the clinical outcome of treatments with three inhibitors of sodium-glucose cotransporter-2 (SGLT2) by Bayesian network meta-analysis, we used PubMed and Embase for randomized controlled trials comparing the efficacy of SGLT2 inhibitors in patients with established CKD. We estimated the composite of cardiorenal outcome of SGLT2 inhibitors versus control by pairwise meta-analysis. We included three trials including four treatment strategies (canagliflozin, dapagliflozin, sotagliflozin, and placebo) that met our inclusion criteria. SGLT2 inhibitors reduced the composite of cardiorenal outcome by 27.5% (OR 0.70, 95% CI 0.57-0.86, I
    MeSH term(s) Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Canagliflozin/adverse effects ; Bayes Theorem ; Diabetes Mellitus, Type 2/drug therapy ; Randomized Controlled Trials as Topic ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/drug therapy
    Chemical Substances Sodium-Glucose Transporter 2 Inhibitors ; dapagliflozin (1ULL0QJ8UC) ; Canagliflozin (0SAC974Z85)
    Language English
    Publishing date 2022-10-25
    Publishing country Netherlands
    Document type Meta-Analysis ; Systematic Review ; Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2022.175354
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Fu chan ke lin chuang chang yong yao wu

    Yang, Se

    [Commonly used drugs in clinical gynecology and obstetrics]

    1974  

    Title translation Commonly used drugs in clinical gynecology and obstetrics.
    Author's details Yang Se, bian
    MeSH term(s) Genital Diseases, Female/drug therapy
    Language Chinese
    Size 4, 56 p.
    Publisher Heh-longjiang ren min zhu ban she
    Publishing place Harbin
    Document type Book
    Note Drug names and index in Chinese and Latin.
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  8. Article ; Online: Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.

    Kao, Yao-Lin / Yang, Wen-Horng / Ou, Chien-Hui

    International urology and nephrology

    2021  Volume 54, Issue 1, Page(s) 63–69

    Abstract: Purpose: The prognosis of patients undergoing 2-sided radical nephroureterectomies (RNUs) with a residual bladder due to bilateral upper tract urothelial carcinoma (UTUC) is poorly understood. This study was aimed toward surveying the oncology outcomes ... ...

    Abstract Purpose: The prognosis of patients undergoing 2-sided radical nephroureterectomies (RNUs) with a residual bladder due to bilateral upper tract urothelial carcinoma (UTUC) is poorly understood. This study was aimed toward surveying the oncology outcomes and prognostic factors that may help in shared decision-making related to bladder preservation in patients preparing to receive 2-sided RNUs.
    Methods: Patients with synchronous or metachronous bilateral UTUC who received bilateral RNUs with a residual bladder in our hospital were retrospectively reviewed. Clinical and pathological data were analyzed for potential variables affecting the oncology outcomes.
    Results: A total of 50 patients were included. The average age at completion of the 2-sided RNU was 62.7 ± 12.4 years, with a mean follow-up of 88.4 ± 59.3 months after the 2-sided RNUs. The medium overall survival was 13.4 ± 1.8 years. Twenty-six patients (52%) had cancer recurrence in the residual bladder, but only 2 (8%) of the recurrences were muscle invasive. The highest UTUC stage was the only predictive factor for cancer-specific survival (CSS) rather than intravesical recurrence. The 5 year CSS rates in patients with the highest UTUC stage ≦ pT2 and ≧ pT3 were 90% and 51%, respectively (p = 0.007).
    Conclusions: Risk of cancer recurrence in the residual bladder is high, but does not affect survival outcomes. The highest UTUC stage plays a significant role in cancer-specific survival. With a careful patient surveillance, bladder preservation may be reasonable in patients with bilateral UTUC preparing for 2-sided RNUs.
    MeSH term(s) Aged ; Carcinoma, Transitional Cell/mortality ; Carcinoma, Transitional Cell/pathology ; Carcinoma, Transitional Cell/surgery ; Female ; Humans ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Nephroureterectomy/methods ; Organ Sparing Treatments/adverse effects ; Prognosis ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Ureteral Neoplasms/mortality ; Ureteral Neoplasms/pathology ; Ureteral Neoplasms/surgery ; Urinary Bladder
    Language English
    Publishing date 2021-11-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 204048-7
    ISSN 1573-2584 ; 0301-1623 ; 0042-1162
    ISSN (online) 1573-2584
    ISSN 0301-1623 ; 0042-1162
    DOI 10.1007/s11255-021-03005-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Application of Plastic Sheet Barrier and Video Intubating Stylet to Protect Tracheal Intubators During Coronavirus Disease 2019 Pandemic

    Hsiang-Ning Luk / Yao-Lin Yang / Phil B. Tsai

    Cell Transplantation, Vol

    A Taiwan Experience

    2021  Volume 30

    Abstract: Since its outbreak in China, the Coronavirus disease 2019 (COVID-19) pandemic has caused worldwide disaster. Globally, there have been 71,581,532 confirmed cases of COVID-19, including 1,618,374 deaths, reported to World Health Organization (data ... ...

    Abstract Since its outbreak in China, the Coronavirus disease 2019 (COVID-19) pandemic has caused worldwide disaster. Globally, there have been 71,581,532 confirmed cases of COVID-19, including 1,618,374 deaths, reported to World Health Organization (data retrieved on December 16, 2020). Currently, no treatment modalities for COVID-19 (e.g., vaccines or antiviral drugs) with confirmed efficacy and safety are available. Although the possibilities and relevant challenges of some alternatives (e.g., use of stem cells as immunomodulators) have been proposed, the personal protective equipment is still the only way to protect and lower infection rates of COVID-19 among healthcare workers and airway managers (intubators). In this article, we described the combined use of a plastic sheet as a barrier with the intubating stylet for tracheal intubation in patients needing mechanical ventilation. Although conventional or video-assisted laryngoscopy is more popular and familiar to other groups around the world, we believe that the video-assisted intubating stylet technique is much easier to learn and master. Advantages of the video stylet include the creation of greater working distance between intubator and patient, less airway stimulation, and less pharyngeal space needed for endotracheal tube advancement. All the above features make this technique reliable and superior to other devices, especially when a difficult airway is encountered in COVID scenario. Meanwhile, we proposed the use of a flexible and transparent plastic sheet to serve as a barrier against aerosol and droplet spread during airway management. We demonstrated that the use of a plastic sheet would not interfere or hinder the intubator’s maneuvers during endotracheal intubation. Moreover, we demonstrated that the plastic sheet was effective in preventing the spread of mist and water spray in simulation models with a mannequin. In our experience, we found that this technique most effectively protected the intubator and other operating room personnel from infection ...
    Keywords Medicine ; R
    Subject code 621
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher SAGE Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article: Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis.

    Liu, Jia-Yang / Dai, Yu / He, Yao-Xi / Lin, Lin

    Frontiers in pharmacology

    2024  Volume 14, Page(s) 1301102

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2024-01-16
    Publishing country Switzerland
    Document type Systematic Review
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2023.1301102
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top